Eisai
4523.T
#2332
Rank
โ‚ฌ7.22 B
Marketcap
25,59ย โ‚ฌ
Share price
0.23%
Change (1 day)
4.37%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): 0,78ย โ‚ฌ

According to Eisai's latest financial reports the company's current EPS (TTM) is 0,76ย โ‚ฌ. In 2026 the company made an earnings per share (EPS) of 0,76ย โ‚ฌ a decrease over its 2025 EPS that were of 0,96ย โ‚ฌ.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
20260,76ย โ‚ฌ-21.04%
20250,96ย โ‚ฌ11.85%
20240,86ย โ‚ฌ-32.63%
20231,27ย โ‚ฌ5.52%
20221,21ย โ‚ฌ-74.01%
20214,65ย โ‚ฌ-66.58%
202013,90ย โ‚ฌ98.24%
20197,01ย โ‚ฌ17.01%
20185,99ย โ‚ฌ37.78%
20174,35ย โ‚ฌ-27.62%
20166,01ย โ‚ฌ35.33%
20154,44ย โ‚ฌ-2.82%
20144,57ย โ‚ฌ-27.66%
20136,32ย โ‚ฌ-27.49%
20128,71ย โ‚ฌ-12.67%
20119,98ย โ‚ฌ88.08%
20105,31ย โ‚ฌ-11.06%
20095,97ย โ‚ฌ-390.15%
2008-2,06ย โ‚ฌ-127.78%
20077,40ย โ‚ฌ347.11%
20061,66ย โ‚ฌ4.38%
20051,59ย โ‚ฌ7.4%
20041,48ย โ‚ฌ43.03%
20031,03ย โ‚ฌ25.09%
20020,83ย โ‚ฌ52.67%
20010,54ย โ‚ฌ69.76%
20000,32ย โ‚ฌ